HONG KONG, March 16, 2023 /PRNewswire/ -- Against all odds, tiger numbers have increased across the world over the past ten years. The individuals, NGOs and governments working hard to protect and save these magnificent cats proved that the threats they face can be reversed, bringing benefits to wildlife and communities alike. Whether it's patrolling the jungle or caring for rescued cubs, CNN's Mission Tiger spotlights the conservation heroes who are passionate about saving these endangered

PR Newswire March 16, 2023

CEAT Specialty (a division of CEAT Tires) has entered into an agreement with CNH Industrial to supply agricultural radial tires for their machines being produced in Brazil and Argentina. MUMBAI, India, March 16, 2023 /PRNewswire/ -- CEAT is proud to announce that CEAT Farmax radials are being fitted in Case IH and New Holland tractors. CEAT PARTNERS WITH CNH INDUSTRIAL FOR AGRICULTURE RADIAL TIRE FITMENTS The agreement was locked after several rounds of assessment and audits

PR Newswire March 16, 2023

Signed a $100 million asset purchase agreement with Shuye of China; secured the world's first mass production system for recycled raw materials and PET The abundant supply of recycled plastic raw materials enables SK chemicals to have the highest level of price competitiveness and facilitates the development of disruptive recycling technologies Targeting the market for high-value-added special materials such as industrial fibers to meet various customer demands such as climate neutralit

PR Newswire March 16, 2023

SHENZHEN, China, March 15, 2023 /PRNewswire/ -- hohem released a new generation of AI auto-tracking professional smartphone gimbal, the iSteady M6. iSteady M6 continues to provide a superior AI auto-tracking function with enhancements. hohem was the first to introduce a gimbal with a magnetic AI auto-tracking device and RGB fill light. The iSteady V2, which was launched in 2021 and featured the AI auto-tracking system, was awarded the coveted Red Dot Design Award in 2022. After e

PR Newswire March 16, 2023

GENEVA, March 15, 2023 /PRNewswire/ -- MedAlliance has announced enrollment of over 1,000 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now a third of the way towards the target of 3,326 patients. SELUTION DeNovo compares the treatment strategy using a novel sirolimus drug-eluting balloon [DEB SELUTION], versus a limus drug-eluting stent [DES]. Over 1,000 Patients Enrolled in Landmark SELUTION DeNovo Study SELUTION DeNovo is the

PR Newswire March 16, 2023

SEOUL, South Korea, March 15, 2023 /PRNewswire/ -- Hyosung Chairman Cho Hyun-joon has set about acquiring human resources to enhance competitiveness in the US power market, the largest market in the world. The company founded a corporation for manufacturing in the US for local production and is now hiring new employees actively. Hyosung HICO, Hyosung Heavy Industries' US subsidiary, is actively hiring employees as it plans to expand its production capacity for transformers. Hyosu

PR Newswire March 16, 2023

Maintained stable business growth and promoted high-quality development HONG KONG and SHANGHAI, March 15, 2023 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An of China," "Ping An," or the "Group," HKEX: 2318; SSE: 601318) today announced its financial results for the year ended December 31, 2022. The year 2022 marked an extraordinary year for Ping An. As a result of the complex and volatile external environme

PR Newswire March 16, 2023

Five posters from Lunit and collaborators demonstrate important progress in the development of novel diagnostics for important cancer therapies, including immunotherapy SEOUL, South Korea, March 15, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading global provider of AI-powered cancer solutions, today announced its participation in the American Association for Cancer Research (AACR) Annual Meeting 2023. Lunit will deliver five poster presentations featuring its AI-biomarker platform

PR Newswire March 16, 2023

RIYADH, Saudi Arabia, March 15, 2023 /PRNewswire/ -- During the Public Investment Fund (PIF) Private Sector Forum in Riyadh today, the Industrialization and Energy Services Company (TAQA)  and Reykjavik Geothermal (RG), signed a Joint Venture agreement to establish TAQA Geothermal Energy LLC, headquartered in Riyadh, Saudi Arabia. TAQA and Reykjavik Geothermal sign Joint Venture Agreement to form TAQA Geothermal Energy LLC TAQA Geothermal will explore and develop Geothermal

PR Newswire March 15, 2023

Industry veteran to spearhead digital solutions delivery for global clients PISCATAWAY, N.J. and BANGALORE, India, March 15, 2023 /PRNewswire/ -- Marlabs Innovation LLC., the global digital solutions company, today announced the induction of Usha Jamadagni into Marlabs executive leadership as Chief Delivery Officer (CDO). Usha will lead Marlabs' global delivery and operations and champion the path to sustainable growth and profitability underlined by a strong people focus. She brings more

PR Newswire March 15, 2023

Applications for physicians trained in Indonesia now open until April 15, 2023 12:00 AM The Pharmaceutical Industry Fellowship Program provides physicians with the opportunity to experience the various steps of the drug development process ROCKVILLE, Md. and SEOUL, South Korea, March 15, 2023 /PRNewswire/ -- HanAll Biopharma Co., Ltd. (KRX: 009420. KS), a global biopharmaceutical company committed to discovering and developing innovative medicines for patients, is now accepting applica

PR Newswire March 15, 2023

The one-of-a-kind B2B platform, developed in partnership with Microsoft, offers a cloud-based infrastructure and ready-to-use digital capabilities for Agri-food Industry. BANGALORE, India, March 15, 2023 /PRNewswire/ -- Sonata Software, a leading Modernization and Digital Engineering company, has announced that it has been chosen as one of the TOP SI partners of the newly launched cloud solution developed by Bayer for the agri-food industry. With the required skills to implement th

PR Newswire March 15, 2023

Presentations highlight the robust tumor growth inhibition in preclinical models for its HER3-targeting programs HMBD-001 (HER3 mAb) and HMBD-501 (HER3 ADC) HMBD-001 used as monotherapy or in combination with cetuximab effectively inhibits tumor growth in preclinical squamous cell carcinoma models HMBD-501 shows superior preclinical efficacy and tolerability compared to other HER3 ADCs across a range of preclinical models, presenting a potentially best-in-class profile SAN FRANCISCO,

PR Newswire March 15, 2023